 Mycobacterium abscessus
"Mycobacterium abscessus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rapidly growing non-tuberculous environmental mycobacterium causing OPPORTUNISTIC INFECTION that infects the skin and subcutaneous tissues. It is associated with HEALTH CARE ASSOCIATED INFECTION and causes serious lung infections in persons with various chronic lung diseases.
| Descriptor ID |
D000073358
|
| MeSH Number(s) |
B03.510.024.049.525.500.720.050 B03.510.460.400.410.552.552.720.050
|
| Concept/Terms |
Mycobacterium abscessus bolletii- Mycobacterium abscessus bolletii
- Mycobacterium abscessus subspecies bolletii
- Mycobacterium abscessus subsp. bolletii
- Mycobacterium bolletii
- Mycobacterium massiliense
Mycobacterium abscessus abscessus- Mycobacterium abscessus abscessus
- Mycobacterium abscessus subsp. abscessus
- Mycobacterium abscessus subspecies abscessus
- Mycobacterium chelonae abscessus
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium abscessus".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium abscessus".
This graph shows the total number of publications written about "Mycobacterium abscessus" by people in this website by year, and whether "Mycobacterium abscessus" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 4 | 0 | 4 | | 2018 | 5 | 0 | 5 | | 2019 | 5 | 2 | 7 | | 2020 | 8 | 0 | 8 | | 2021 | 10 | 0 | 10 | | 2022 | 7 | 0 | 7 | | 2023 | 5 | 0 | 5 | | 2024 | 5 | 0 | 5 | | 2025 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Mycobacterium abscessus" by people in Profiles.
-
Singh N, Dangi B, Johnson JJ, Louie A, Karunanidhi A, Curry BN, Mitarai S, Daley CL, Hobbie SN, Bulman ZP. Pharmacodynamic assessment of apramycin against Mycobacterium abscessus in a hollow fibre infection model. J Antimicrob Chemother. 2025 May 02; 80(5):1309-1314.
-
Wheeler EA, Lenhart-Pendergrass PM, Rysavy NM, Poch KR, Caceres SM, Calhoun KM, Serban KA, Nick JA, Malcolm KC. Divergent host humoral innate immune response to the smooth-to-rough adaptation of Mycobacterium abscessus in chronic infection. Front Cell Infect Microbiol. 2025; 15:1445660.
-
Nguyen MH, Calado Nogueira de Moura V, Keepers TR, van Ingen J, Daley CL. In vitro susceptibility of 147 international clinical Mycobacterium abscessus isolates to epetraborole and comparators by broth microdilution. J Antimicrob Chemother. 2025 Mar 03; 80(3):713-716.
-
Shin E, Dousa KM, Taracila MA, Bethel CR, Nantongo M, Nguyen DC, Akusobi C, Kurz SG, Plummer MS, Daley CL, Holland SM, Rubin EJ, Bulitta JB, Boom WH, Kreiswirth BN, Bonomo RA. Durlobactam in combination with ?-lactams to combat Mycobacterium abscessus. Antimicrob Agents Chemother. 2025 Feb 13; 69(2):e0117424.
-
Dousa KM, Shin E, Kurz SG, Plummer M, Nantongo M, Bethel CR, Taracila MA, Nguyen DC, Kreiswith BN, Daley CL, Remy KE, Holland SM, Bonomo RA. Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus. mBio. 2024 Jun 12; 15(6):e0060924.
-
Nguyen MH, Hasan NA, De Moura VCN, Epperson LE, Czaja CA, Johnston H, Laramee N, Orten K, Rivas J, Prasai S, Grossman MK, Perkins KM, Griffith DE, Khare R, Strong M, Daley CL. Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico - Arizona and Colorado, 2022. MMWR Morb Mortal Wkly Rep. 2024 May 09; 73(18):420-422.
-
Chen L, Shashkina E, Kurepina N, Calado Nogueira de Moura V, Daley CL, Kreiswirth BN. In vitro activity of cefoxitin, imipenem, meropenem, and ceftaroline in combination with vaborbactam against Mycobacterium abscessus. Antimicrob Agents Chemother. 2024 05 02; 68(5):e0017424.
-
Dartois V, Bonfield TL, Boyce JP, Daley CL, Dick T, Gonzalez-Juarrero M, Gupta S, Kramnik I, Lamichhane G, Laughon BE, Lor? NI, Malcolm KC, Olivier KN, Tuggle KL, Jackson M. Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations. Tuberculosis (Edinb). 2024 Jul; 147:102503.
-
Born SEM, Reichlen MJ, Bartek IL, Benoit JB, Frank DN, Voskuil MI. Population heterogeneity in Mycobacterium smegmatis and Mycobacterium abscessus. Microbiology (Reading). 2023 10; 169(10).
-
El Ghali A, Morrisette T, Alosaimy S, Lucas K, Tupayachi-Ortiz MG, Vemula R, Wadle C, Philley JV, Mejia-Chew C, Hamad Y, Stevens RW, Zeuli JD, Webb AJ, Fiske CT, Simonyan A, Cimino CL, Mammadova M, Umana VE, Hasbun R, Butt S, Molina KC, Thomas M, Kaip EA, Bouchard J, Gore TW, Howard C, Cabanilla MG, Holger DJ, Frens JJ, Barger M, Ong A, Cohen KA, Rybak MJ. Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes. Antimicrob Agents Chemother. 2023 10 18; 67(10):e0082423.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|